Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Continuous Manufacturing: Cost, Lack Of Know-How Have Deterred Generic Firms, Prof Says
Feb 25 2020
•
By
Brenda Sandburg
Hearing focuses on bill intended to expand use of continuous manufacturing
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance